SYRS logo

Syros Pharmaceuticals (SYRS) Return On Equity

Annual ROE

-227.95%
-139.05%-156.41%

December 31, 2023


Summary


Performance

SYRS ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSYRSprofitabilitymetrics:

Quarterly ROE

-2746.84%
-1893.50%-221.89%

September 30, 2024


Summary


Performance

SYRS Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSYRSprofitabilitymetrics:

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

SYRS ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-156.4%-2376.6%
3 y3 years-130.2%-2593.5%
5 y5 years-163.4%-2593.5%

SYRS ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-156.4%at low-3465.0%at low
5 y5-year-156.4%at low-3465.0%at low
alltimeall time-922.2%at low-4447.8%at low

Syros Pharmaceuticals ROE History

DateAnnualQuarterly
Sep 2024
-
-2746.84%(+221.9%)
Jun 2024
-
-853.34%(+108.6%)
Mar 2024
-
-409.15%(+79.3%)
Dec 2023
-227.95%(+156.4%)
-228.14%(+105.7%)
Sep 2023
-
-110.91%(+9.2%)
Jun 2023
-
-101.59%(-0.4%)
Mar 2023
-
-101.98%(-6.1%)
Dec 2022
-88.90%(-9.7%)
-108.58%(-20.9%)
Sep 2022
-
-137.24%(+4.1%)
Jun 2022
-
-131.88%(+44.5%)
Mar 2022
-
-91.29%(+18.5%)
Dec 2021
-98.49%(-0.5%)
-77.05%(-13.3%)
Sep 2021
-
-88.89%(-1.4%)
Jun 2021
-
-90.16%(-5.4%)
Mar 2021
-
-95.27%(-19.6%)
Dec 2020
-99.02%
-118.49%(+15.4%)
Sep 2020
-
-102.66%(+17.9%)
Jun 2020
-
-87.07%(-2.6%)
DateAnnualQuarterly
Mar 2020
-
-89.39%(+1.5%)
Dec 2019
-95.63%(+10.5%)
-88.07%(+6.0%)
Sep 2019
-
-83.05%(+9.2%)
Jun 2019
-
-76.06%(+6.6%)
Mar 2019
-
-71.32%(+3.5%)
Dec 2018
-86.55%(+16.9%)
-68.90%(+4.6%)
Sep 2018
-
-65.88%(+2.5%)
Jun 2018
-
-64.30%(-7.5%)
Mar 2018
-
-69.52%(-0.7%)
Dec 2017
-74.02%(-11.1%)
-70.01%(+15.9%)
Sep 2017
-
-60.40%(-6.8%)
Jun 2017
-
-64.79%(-4.5%)
Mar 2017
-
-67.82%(-8.3%)
Dec 2016
-83.28%(+31.7%)
-73.96%(-5.7%)
Sep 2016
-
-78.41%(-5.3%)
Jun 2016
-
-82.77%(+13.1%)
Mar 2016
-
-73.16%(-16.5%)
Dec 2015
-63.25%(+183.6%)
-87.57%
Dec 2014
-22.30%
-

FAQ

  • What is Syros Pharmaceuticals annual return on equity?
  • What is the all time high annual ROE for Syros Pharmaceuticals?
  • What is Syros Pharmaceuticals annual ROE year-on-year change?
  • What is Syros Pharmaceuticals quarterly return on equity?
  • What is the all time high quarterly ROE for Syros Pharmaceuticals?
  • What is Syros Pharmaceuticals quarterly ROE year-on-year change?

What is Syros Pharmaceuticals annual return on equity?

The current annual ROE of SYRS is -227.95%

What is the all time high annual ROE for Syros Pharmaceuticals?

Syros Pharmaceuticals all-time high annual return on equity is -22.30%

What is Syros Pharmaceuticals annual ROE year-on-year change?

Over the past year, SYRS annual return on equity has changed by -139.05% (-156.41%)

What is Syros Pharmaceuticals quarterly return on equity?

The current quarterly ROE of SYRS is -2746.84%

What is the all time high quarterly ROE for Syros Pharmaceuticals?

Syros Pharmaceuticals all-time high quarterly return on equity is -60.40%

What is Syros Pharmaceuticals quarterly ROE year-on-year change?

Over the past year, SYRS quarterly return on equity has changed by -2635.93% (-2376.64%)